Skip to main content

Shah Nimish P's Form 4 filing

Apogee Therapeutics, Inc. (APGE) · filed Sep 3, 2026

Accession no.
0001140361-26-035608
Filed
Sep 3, 2026, 4:39 PM ET
Trade date
Sep 3, 2026
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 6 derivative transactions. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Shah Nimish PCIK 0001698082Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 3, 2026Common StockDReturned to the companyDisposed−1,750,000$135.11−$236,442,5000Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 3, 2026Common StockDReturned to the companyDisposed−6,743,321$135.11−$911,090,100.310Indirect
Sep 3, 2026Common StockDReturned to the companyDisposed−47,758––0Direct
Sep 3, 2026Common StockDReturned to the companyDisposed−10,370––0Direct
Sep 3, 2026Common StockDReturned to the companyDisposed−14,461––0Direct
Sep 3, 2026Common StockDReturned to the companyDisposed−7,657––0Direct
Sep 3, 2026Common StockDReturned to the companyDisposed−365,853––0Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)